COVID-19 testing
COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2, the virus that cases COVID-19 and is responsible for the COVID-19 pandemic. The two main types of tests detect either the presence of the virus or antibodies produced in response to infection.[1][2] Molecular tests for viral presence through its molecular components are used to diagnose individual cases and to allow public health authorities to trace and contain outbreaks. Antibody tests (serology immunoassays) instead show whether someone once had the disease.[3] They are less useful for diagnosing current infections because antibodies may not develop for weeks after infection.[4] It is used to assess disease prevalence, which aids the estimation of the infection fatality rate.[5]
Individual jurisdictions have adopted varied testing protocols, including whom to test, how often to test, analysis protocols, sample collection and the uses of test results.[6][7][8] This variation has likely significantly impacted reported statistics, including case and test numbers, case fatality rates and case demographics.[9][10][11][12] Because SARS-CoV-2 transmission occurs days after exposure (and before onset of symptoms), there is an urgent need for frequent surveillance and rapid availability of results.[13]
Test analysis is often performed in automated, high-throughput, medical laboratories by medical laboratory scientists. Rapid self-tests and point-of-care testing are also available and can offer a faster and less expensive method to test for the virus although with a lower accuracy.[14][15]
A PCR machine
Testing protocols
Drive-through testing
In drive-through testing, the person undergoing testing remains in a vehicle while a healthcare professional approaches the vehicle and obtains a sample, all while taking appropriate precautions such as wearing personal protective equipment (PPE).[118][119] Drive-through centers helped South Korea accelerate its testing program.[120]
Confirmatory testing
The WHO recommends countries that do not have testing capacity and national laboratories with limited experience on COVID-19 send their first five positives and the first ten negative COVID-19 samples to one of the 16 WHO reference laboratories for confirmatory testing.[199][200] Out of the sixteen reference laboratories, seven are in Asia, five in Europe, two in Africa, one in North America and one in Australia.[201]
National or regional responses
Iceland
Iceland managed the pandemic with aggressive contact tracing, inbound travel restrictions, testing, and quarantining, but with less aggressive lock-downs.[202]
This article incorporates from Symptom-Based Strategy to Discontinue Isolation for Persons with COVID-19. Centers for Disease Control and Prevention. Retrieved 5 May 2020.
